Approval · Notice of Compliance 31340 · 2023
ELTROXIN: Notice of Compliance 31340
Issued July 31, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31340
- Date
- July 31, 2023
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update to the Product Monograph.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELTROXIN | Not yet assigned | — |
Medicinal ingredients
- LEVOTHYROXINE SODIUM 50 MCG per TAB
- LEVOTHYROXINE SODIUM 100 MCG per TAB
- LEVOTHYROXINE SODIUM 150 MCG per TAB
- LEVOTHYROXINE SODIUM 200 MCG per TAB